Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Psychiatry
•
General Psychiatry
•
Neuromodulation
•
Ketamine
What criteria do you use when deciding whether to start esketamine treatment for patients with treatment resistant MDD who are concomitant CNS depressants?
Related Questions
How do you approach tapering electroconvulsive therapy after an acute treatment course leading to successful resolution of symptoms for treatment-resistant depression?
What is your experience with transcutaneous vagal nerve stimulation for treatment of anxiety disorders and major depressive disorder?
How do you use TMS for tinnitus? Where do you target, and what settings on the magnet do you use? Is anyone using either iTBS or cTBS for this!?
How do you determine the treatment course of esketamine or IV ketamine when used for treatment-resistant major depressive disorder?
What pharmacologic therapy, if any, do you recommend for treatment of borderline personality disorder?
How do you approach patient requests for medical time away from work or other accommodations (such as disability paperwork) when the patients have mild-moderate symptoms being managed in the outpatient setting?
Do you believe that buspirone is ineffective in patients who are previously treated with benzodiazepines?
Is there evidence to suggest there is a withdrawal syndrome from muscle relaxants such as tizanidine?
What do you do when a patient experiences multiple rounds of antidepressant-related tachyphylaxis?
What medications best treat Intermittent Explosive Disorder?
